WOCKPHARMA.NS
Wockhardt Ltd
Price:  
2,031.40 
INR
Volume:  
13,172,612.00
India | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

WOCKPHARMA.NS WACC - Weighted Average Cost of Capital

The WACC of Wockhardt Ltd (WOCKPHARMA.NS) is 12.7%.

The Cost of Equity of Wockhardt Ltd (WOCKPHARMA.NS) is 13.05%.
The Cost of Debt of Wockhardt Ltd (WOCKPHARMA.NS) is 9.50%.

Range Selected
Cost of equity 11.50% - 14.60% 13.05%
Tax rate 14.80% - 22.70% 18.75%
Cost of debt 9.00% - 10.00% 9.50%
WACC 11.2% - 14.1% 12.7%
WACC

WOCKPHARMA.NS WACC calculation

Category Low High
Long-term bond rate 6.9% 7.4%
Equity market risk premium 8.3% 9.3%
Adjusted beta 0.56 0.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 11.50% 14.60%
Tax rate 14.80% 22.70%
Debt/Equity ratio 0.08 0.08
Cost of debt 9.00% 10.00%
After-tax WACC 11.2% 14.1%
Selected WACC 12.7%

WOCKPHARMA.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for WOCKPHARMA.NS:

cost_of_equity (13.05%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.56) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.